It is estimated that 50% of cancers are the outcome of alteration/mutations in the p53 gene [12], whereas in the remaining 50% of tumors the p53 wild type is retained but with inhibited cell cycle arrest [5,13]. The gene discussed is TP53; the disease is cancer.